RS52904B - Microrna (mirna) mir-21 for diagnostic and therapeutic purposes - Google Patents

Microrna (mirna) mir-21 for diagnostic and therapeutic purposes

Info

Publication number
RS52904B
RS52904B RS20130340A RSP20130340A RS52904B RS 52904 B RS52904 B RS 52904B RS 20130340 A RS20130340 A RS 20130340A RS P20130340 A RSP20130340 A RS P20130340A RS 52904 B RS52904 B RS 52904B
Authority
RS
Serbia
Prior art keywords
mir
microrna
mirna
diagnostic
therapeutic purposes
Prior art date
Application number
RS20130340A
Other languages
Serbian (sr)
Inventor
Thomas Thum
Johann Bauersachs
Stefan Engelhardt
Carina Gross
Original Assignee
Julius-Maximilians-Universität Würzburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20080003570 external-priority patent/EP2096171A1/en
Application filed by Julius-Maximilians-Universität Würzburg filed Critical Julius-Maximilians-Universität Würzburg
Publication of RS52904B publication Critical patent/RS52904B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Jedinjenje, naznačeno time, da sadrži modifikovani oligonukleotid koji obuhvata 12 do 30 spojenih nukleozida, pri čemu modifikovani oligonukleotid ima nukleobaznu sekvencu koja je komplementarna sa miR-21 ili njenim prekursorom, za upotrebu u tretmanu, prevenciji ili dijagnozi fibroze u nekom subjektu.Prijava sadrži još 14 patentnih zahteva.A compound comprising a modified oligonucleotide comprising 12 to 30 fused nucleosides, wherein the modified oligonucleotide has a nucleobase sequence that is complementary to miR-21 or its precursor for use in the treatment, prevention or diagnosis of fibrosis in an entity. another 14 patent claims.

RS20130340A 2008-02-27 2009-02-26 Microrna (mirna) mir-21 for diagnostic and therapeutic purposes RS52904B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3183508P 2008-02-27 2008-02-27
EP20080003570 EP2096171A1 (en) 2008-02-27 2008-02-27 MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes
US3334008P 2008-03-03 2008-03-03
EP09051986 2009-02-19
PCT/EP2009/001590 WO2009106367A1 (en) 2008-02-27 2009-02-26 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes

Publications (1)

Publication Number Publication Date
RS52904B true RS52904B (en) 2014-02-28

Family

ID=49640278

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20130340A RS52904B (en) 2008-02-27 2009-02-26 Microrna (mirna) mir-21 for diagnostic and therapeutic purposes

Country Status (3)

Country Link
NZ (1) NZ600482A (en)
RS (1) RS52904B (en)
ZA (1) ZA201005998B (en)

Also Published As

Publication number Publication date
NZ600482A (en) 2013-11-29
ZA201005998B (en) 2015-04-29

Similar Documents

Publication Publication Date Title
JP2012228254A5 (en)
NZ624783A (en) Modulation of huntingtin expression
EA201070421A1 (en) MICRORIPONIC ACID
NZ630596A (en) Methods for treatment of alport syndrome
MX2023008408A (en) Antisense compositions and methods of making and using same.
HRP20110861T1 (en) Drug for treatment of influenza
JP2013226147A5 (en)
DK2049664T3 (en) Single-stranded oligonucleotides, complementary to repetitive elements, for the treatment of DNA repetitive instability-associated disorders
EA201100810A1 (en) PHARMACEUTICAL COMPOSITION
CL2009002206A1 (en) Compounds derived from pyrrolo - (2-3-d] -pyrimidin-7 (6h) -tetrahydrofuran-2-yl phosphonamidate, pharmaceutical composition; and its use in the treatment of viral diseases.
MX2013005875A (en) Microrna inhibitors comprising locked nucleotides.
BR112015000710A8 (en) OLIGONUCLEOTIDES TO MAKE A SEQUENCE CHANGE IN A TARGET RNA MOLECULE PRESENT IN A LIVING CELL
MX359548B (en) Modified rnai agents.
ZA201404444B (en) 4'-azido,3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
BR112014032239A2 (en) inhibitors of the micro-rnas mir-15 family
WO2005116250A3 (en) Viral and viral associated mirnas and uses thereof
WO2016061232A3 (en) Multiplexed shrnas and uses thereof
MY155564A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
WO2006121464A3 (en) Compositions for treating respiratory viral infections and their use
BR112017013765A2 (en) methods for using smad7 antisense oligonucleotides
MX2015015781A (en) 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives.
MX2018006445A (en) Il-34 antisense oligonucleotides and methods of using same.
RS52904B (en) Microrna (mirna) mir-21 for diagnostic and therapeutic purposes
MX2021010255A (en) Fragile x mental retardation protein interfering oligonucleotides and methods of using same.
PL398796A1 (en) The use of miRNA molecules and antagomir for miRNA in the diagnosis, prevention and treatment of multiple sclerosis